1. Rational use of dioxidine for treatment of purulent infections (based on the results of a clinical study);E.N. Padeiskaya,1984
2. Padeiskaya, E.N., Antibacterial drug dioxidin: specific biological action and role in the treatment of various forms of purulent infection, Infekts. Antimikrob. Ter., 2001, no. 5, pp. 150–155.
3. Popov, D.A., Anuchina, N.M., Terent’ev, A.A., et al., Dioxidine: antimicrobial activity and possible clinical application at the present stage, Antibiot. Khimioter., 2013, vol. 58, nos. 3–4, pp. 37–42.
4. Fonshtein, L.M., Abilev, S.K., Akin’shina, L.P., et al., Investigation of the genetic effects of drugs and other biologically active compounds in tests for mutagenesis and DNA-damaging action, Pharm. Chem. J., 1982, vol. 16, no. 10, pp. 721–726.
5. Fonstein, L.M., Revazova, Yu.A., Zolotareva, G.N., et al., The mutagenic activity of dioxidine, Genetika, 1985, vol. 21, no. 5, pp. 11–19.